ACE inhibitors prevent angiotensin I from changing to angiotensin II, ARBS avoid the binding of angiotensin II on to blood vessel receptors From the Ph2b demo, ibezapolstat-dealt with people confirmed decrease concentrations of fecal primary bile acids, and higher useful ratio of secondary to Pri